Category Archives: CHARM

  1. Rectal microbicide research gives hope for HIV protection

    via Citizens News Service, by Somya Arora According to the Microbicides Trials Network (MTN), HIV continues to disproportionately affect racial minorities and men who have sex with men (MSM). MTN estimates that 5 to 10 percent of the world’s population engages in anal sex and globally, MSM are 19 times more likely to be infected with HIV Read More >>

    AIDS Foundation of Chicago, anal sex, antiretroviral therapy, CHARM, Dr. Ian McGowan, HIV, HIV transmission, HIV/AIDS, IRMA, Jim Pickett, Microbicide Trials Network, MSM, MTN, rectal microbicide, STI
  2. Did you miss the IRMA/AVAC teleconference on the CHARM program? You’re in luck…

    The teleconference I am referring to – “And in the beginning, there were Rectal Microbicides” – was held last Thursday. The slides and call recording are available now. It was a really interesting call – with LOTS of great questions from the participants. Thanks to everyone who made it so dynamic – including presenter Ian McGowan and Read More >>

    ARV, CHARM, HIV, HIV/AIDS, IRMA, MTN, rectal microbicide
  3. And in the Beginning, There Were Rectal Microbicides: An Update on the CHARM Program

    Please Register for this Teleconference!  Please join IRMA, AVAC and Ian McGowan, co-principal investigator of the Microbicide Trials Network and Principal Investigator of CHARM (the Combination HIV Antiretroviral Rectal Microbicide Program) for a thoroughly CHARMing teleconference update on what is happening with this innovative program. Funded by the U.S. National Institutes of Health in 2009, CHARM is Read More >>

    AVAC, CHARM, Dr. Ian McGowan, IRMA, Microbicide Trials Network, Microbicides, MTN, rectal microbicide, teleconference
  4. $17 million grant to help Pitt researcher develop anti-HIV gel

    via Pittsburgh Post-Gazette, by David Templeton Highlight: Dr. McGowan said the size of the NIH grants reflects a change in Washington, D.C., where the Obama administration has shown greater interest in funding HIV-prevention research. “The Bush administration had a very high level of discomfort embracing HIV prevention research in men,” he said. “But I think in the Read More >>

    behavioral research, CHARM, Dr. Alex Carballo-Dieguez, Dr. Ian McGowan, MTN, NIH, Pittsburgh, rectal microbicide
  5. Pitt Receives Grants Totaling $17.5 million for Two HIV Prevention Projects: Multicenter Studies Will Develop Rectal Microbicides and Assess Their Acceptance

    via Erie Gay News A multicenter research team led by the University of Pittsburgh is developing microbicides specifically designed to prevent rectal transmission of HIV, with the further aim of assessing their safety and efficacy in lab and early clinical studies. Funded by an $11 million, five-year grant from the National Institutes of Health, the Combination HIV Read More >>

    CHARM, Dr. Ian McGowan, NIH, Pittsburgh, rectal microbicide, vaginal microbicide
  6. Magee-Womens Research Institute Receives $17.5 million for Rectal Microbicide Research

    Dr. Ian McGowan* (pictured), an investigator with the Magee-Womens Research Institute (MWRI), recently received a total of $17.5 million from the National Institutes of Health (NIH) to conduct two studies involving the development of rectal microbicides. “This is exciting for the field of HIV prevention research, and especially important in terms of moving the research and development Read More >>

    acceptability, CHARM, Dr. Alex Carballo-Dieguez, Dr. Ian McGowan, IRMA, MTN, new prevention technologies, NIH, rectal microbicide